Ahmed Samir Abdelhafiz (Ahmed S Abdelhafiz)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Herpes Simplex Virus

Acute Lymphoblastic Leukemia

Top Venues

International journal of immunopathology and pharmacology

Wellcome open research

This page only lists publications with an associated author ORCID identifier.

Publications

Noha Gaber, Ahmed Samir Abdelhafiz, Nivin Abdel-Azim, Azza Shibl, Lamiaa Fadel, Zeinab Korany Hassan, Eman Hassan Ahmed
HERV-K np9 and HERV-R env: Two endogenous retrovirus products with potential Pathogenic roles in pediatric acute lymphoblastic leukemia. International journal of immunopathology and pharmacology 38 (2024)
Noha Gaber, Ahmed Samir Abdelhafiz, Nivin Abdel-Azim, Azza Shibl, Lamiaa Fadel, Zeinab Korany Hassan, Eman Hassan Ahmed
HERV-K np9 and HERV-R env: Two endogenous retrovirus products with potential Pathogenic roles in pediatric acute lymphoblastic leukemia. International journal of immunopathology and pharmacology 38 (2024)
Noha Gaber, Ahmed Samir Abdelhafiz, Nivin Abdel-Azim, Azza Shibl, Lamiaa Fadel, Zeinab Korany Hassan, Eman Hassan Ahmed
HERV-K np9 and HERV-R env: Two endogenous retrovirus products with potential Pathogenic roles in pediatric acute lymphoblastic leukemia. International journal of immunopathology and pharmacology 38 (2024)
Asmaa Ali, Ahmed Samir Abdelhafiz, Mai M Saleh, Heba Salem, Mohammed A Rakha, Seham Ezzat
Monocyte to eosinophil ratio as a diagnostic biomarker for overlap syndrome and predictor of disease exacerbation. International journal of immunopathology and pharmacology 37 (2023)
Ahmed Samir Abdelhafiz, Asmaa Ali, Mahmoud M Kamel, Eman Hasan Ahmed, Douaa M Sayed, Rania M Bakry
Sinopharm's BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2. Vaccines 10 (9) (2022)
Ahmed Samir Abdelhafiz, Asmaa Ali, Ayman Mohamed Maaly, Mohamed Anwar Mahgoub, Hany Hassan Ziady, Eman Anwar Sultan
Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated. PloS one 17 (3) (2022)
Ahmed Samir Abdelhafiz, Calvin Wai-Loon Ho, Teck Chuan Voo
Recommendations for the development of Egyptian human biobanking ethical guidelines. Wellcome open research 6 (2021)
Ahmed Samir Abdelhafiz, Calvin Wai-Loon Ho, Teck Chuan Voo
Recommendations for the development of Egyptian human biobanking ethical guidelines. Wellcome open research 6 (2021)
Ahmed Samir Abdelhafiz, Eman Anwar Sultan, Hany H Ziady, Douaa M Sayed, Walaa A Khairy
Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues. PloS one 16 (3) (2021)
Ahmed Samir Abdelhafiz, Ghada M Elsayed, Magdy M Saber, Abdallah Gameel, Nayera Hamdy
Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML. International journal of laboratory hematology 42 (3) (2020)
Ahmed Samir Abdelhafiz, Mona Wassef, Mohamed Alorabi
Pleural empyema due to Salmonella in a patient with bronchogenic carcinoma: the first case report from a cancer hospital in Egypt. Access microbiology 2 (9) (2020)
Ahmed Samir Abdelhafiz, Eman A Sultan, Hany H Ziady, Ebtesam Ahmed, Walaa A Khairy, Douaa M Sayed, Rana Zaki, Merhan A Fouda, Rania M Labib
What Egyptians think. Knowledge, attitude, and opinions of Egyptian patients towards biobanking issues. BMC medical ethics 20 (1) (2019)